Young-Chul Chung, M.D., Ph.D., is a professor of psychiatry, Chonbuk National University Medical School, Jeonju, Korea. He is a president of the Korean Society of Schizophrenia Research (2016-2017), council member of Asian College of Neuropsychopharmacology (2017-2020), education committee member for the CINP (2016-2018), and chairman of the Asian Network of Early Psychosis. He serves as editorial board for Early Intervention in Psychiatry, and East Asian Archives of Psychiatry and international advisory board for Taiwanese Journal of Psychiatry.
Young-Chul received the Paul Janssen Schizophrenia Research Award (2011) from the Korean Neuropsychiatric Association, Otsuka Academic Award (2013) from the Korean College of Neuropsychopharmacology, and Lilly Research Award (2014) from the Korean Neuropsychiatric Association. He worked as a research Fellow at Vanderbilt University Medical Center (Psychopharmacology Division, Department of Psychiatry), US (2001-2003) and academic fellow at Orygen Youth Health (EPPIC), Melbourne University, Australia (2003-2003).
His main interests are schizophrenia, psychopharmacology, cognitive-behavioral therapy, epigenetics, and brain imaging. Now he is conducting “Prospective Establishment and Study of First Episode Psychosis Cohort” (2014-2019 Korea-National Institute of Mental Health) and “Susceptibility to social defeat stress: behavioral, genetic, molecular and brain imaging study” (2015-2018 Korea Research Foundation).